Report

Global Viscosupplementation Market Size study, by Product Type (Single Injection, Three injections, Five Injection), by End use(Hospitals, Orthopedic Clinics/Ambulatory Surgical Centres (ASCS) and Others), and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Viscosupplementation Market , by Region, 2019-2027 (USD Billion)
1.2.2. Viscosupplementation Market, by Product Type, 2019-2027 (USD Billion)
1.2.3. Viscosupplementation Market, by End Use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Viscosupplementation Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Viscosupplementation Market Dynamics
3.1. Viscosupplementation Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of osteoarthritis among geriatric population
3.1.1.2. New product development
3.1.2. Market Restraint
3.1.2.1. High cost of products
3.1.2.2. Side effects associated with hyaluronic acid cycles
3.1.3. Market Opportunities
3.1.3.1. Approvals for three-injection viscosupplements
Chapter 4. Global Viscosupplementation Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Viscosupplementation Market, by Product Type
5.1. Market Snapshot
5.2. Global Viscosupplementation Market by Product Type, Performance - Potential Analysis
5.3. Global Viscosupplementation Market Estimates & Forecasts by Product Type 2018-2027 (USD Billion)
5.4. Viscosupplementation Market, Sub Segment Analysis
5.4.1. Single Injection
5.4.2. Three injections
5.4.3. Five Injection
Chapter 6. Global Viscosupplementation Market, by End Use
a. Market Snapshot
6.1. Global Viscosupplementation Market by End Use, Performance - Potential Analysis
6.2. Global Viscosupplementation Market Estimates & Forecasts by End Use2018-2027 (USD Billion)
6.3. Viscosupplementation Market, Sub Segment Analysis
6.3.1. Hospitals
6.3.2. Orthopedic Clinics/Ambulatory Surgical Centres (ASCS)
6.3.3. Others
Chapter 7. Global Viscosupplementation Market, Regional Analysis
7.1. Viscosupplementation Market, Regional Market Snapshot
7.2. North America Viscosupplementation Market
7.2.1. U.S. Viscosupplementation Market
7.2.1.1. Product Type breakdown estimates & forecasts, 2018-2027
7.2.1.2. End Usebreakdown estimates & forecasts, 2018-2027
7.2.2. Canada Viscosupplementation Market
7.3. Europe Viscosupplementation Market Snapshot
7.3.1. U.K. Viscosupplementation Market
7.3.2. Germany Viscosupplementation Market
7.3.3. France Viscosupplementation Market
7.3.4. Spain Viscosupplementation Market
7.3.5. Italy Viscosupplementation Market
7.3.6. Rest of Europe Viscosupplementation Market
7.4. Asia-Pacific Viscosupplementation Market Snapshot
7.4.1. China Viscosupplementation Market
7.4.2. India Viscosupplementation Market
7.4.3. Japan Viscosupplementation Market
7.4.4. Australia Viscosupplementation Market
7.4.5. South Korea Viscosupplementation Market
7.4.6. Rest of Asia Pacific Viscosupplementation Market
7.5. Latin America Viscosupplementation Market Snapshot
7.5.1. Brazil Viscosupplementation Market
7.5.2. Mexico Viscosupplementation Market
7.6. Rest of The World Viscosupplementation Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. Sanofi
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Anika Therapeutics, Inc.
8.2.3. Seikagaku corporation
8.2.4. Zimmer Biomet
8.2.5. Smith & Nephew PLC
8.2.6. Ferring Pharmaceuticals B.V
8.2.7. Lifecore Biomedical, LLC (Landec)
8.2.8. LG Life Sciences Ltd.
8.2.9. Fidia Farmaceutici S.p.A
8.2.10. F.Hoffmann-La Roche Ltd.

Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption